LigaSure technique of haemorrhoidectomy versus Ferguson Clinic haemorrhoidectomy: a randomised prospective study

ISRCTN ISRCTN28708390
DOI https://doi.org/10.1186/ISRCTN28708390
Protocol serial number N0436165617
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funder Leeds Teaching Hospitals NHS Trust
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
17/10/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr A Abdulgader
Scientific

LIMIT - Leeds Institute for Minimally Invasive The
6th Floor, Wellcome Wing
Great George Street
Leeds
LS1 3EX
United Kingdom

Phone +44 (0)113 392 3557
Email abdulmoniem.abdulgader@leedsth.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleLigaSure technique of haemorrhoidectomy versus Ferguson Clinic haemorrhoidectomy: a randomised prospective study
Study objectivesThe study is designed to compare Ferguson clinic closed haemorrhoidectomy with LigaSure haemorrhoidectomy. The primary end points of the study is the assessment of postoperative pain, morbidity and time to full recovery.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Haemorrhoidectomy
InterventionFerguson clinic closed haemorrhoidectomy vs LigaSure haemorrhoidectomy.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

1. Visual analogue of postoperative pain on a daily basis for one week, followed by pain scores at two and four weeks as well as overall satisfaction
2. Pre and postoperative anorectal physiology and endoanal ultrasonography (12 weeks post operative)
3. Postoperative complications: a) infection; b) wound dehiscence; c) haemorrhage

Key secondary outcome measure(s)

No secondary outcome measures

Completion date01/01/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteriaSubjects with history of 3rd degree haemorrhoids.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2003
Date of final enrolment01/01/2004

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

LIMIT - Leeds Institute for Minimally Invasive The
Leeds
LS1 3EX
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Editorial Notes

17/10/2016: No publications found in PubMed, verifying study status with principal investigator.